Avoiding analgesic escalation and excessive healthcare utilization in severe irritable bowel syndrome: a role for intramuscular anticholinergics?
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Objectives: In patients with severe irritable bowel syndrome (IBS), abdominal pain can be the predominant symptom impacting on all aspects of their lives and resulting in excessive healthcare utilization. Furthermore, the use of analgesics can become excessive in this group of patients, sometimes leading to opiate dependency. Typically, the pain is often described as spastic in nature and we have speculated that parenteral anticholinergics might provide effective relief when all other measures have failed. For several years, we have therefore been asking general practitioners to consider teaching such patients to administer intramuscular hyoscine butylbromide for pain episodes and this study is an audit of this approach. Methods: Patients in whom the use of intramuscular hyoscine butylbromide had been recommended to their general practitioner in the last three years were interviewed over the telephone in order to document the efficacy of this approach as well as any potential disadvantages. Results: A total of 122 general practitioners were advised to try this approach, with 58 agreeing to teach the technique and prescribe the medication. Of the 58 patients who used the medication, 50 (86%) found it gave them pain relief, which was complete in six (10%), substantial in 36 (62%) and mild in eight (14%), with 15 (26%) decreasing the use of analgesics and 13 (32%) of the 41 taking opiates able to reduce or stop them completely. Side effects were few and largely consisted of those associated with anticholinergics. Only four patients stopped medication because of side effects and no major skin reactions were reported. Conclusions: The use of intramuscular hyoscine butylbromide shows promise in the management of IBS when severe unmanageable abdominal pain is a major problem. This approach appears to be safe and has the potential to reduce analgesic escalation, opiate dependency and attendances at accident and emergency departments.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Ford, A. C., Talley, N. J., Schoenfeld, P. S., Quigley, E. M. M., & Moayyedi, P. (2009) · Gut · doi:10.1136/gut.2008.163162 · Cited by 582
Ford, A. C., Talley, N. J., Spiegel, B. M. R., Foxx-Orenstein, A. E., Schiller, L., Quigley, E. M. M., & Moayyedi, P. (2008) · BMJ · doi:10.1136/bmj.a2313 · Cited by 565
Non-colonic features of irritable bowel syndrome.
Whorwell, P. J., McCallum, M., Creed, F. H., & Roberts, C. T. (1986) · Gut · doi:10.1136/gut.27.1.37 · Cited by 473 · cited 1×
“Such symptoms can include typical features such as abdominal pain, abdominal bloating and bowel dysfunction, but noncolonic complaints such as low backache, constant lethargy, nausea and bladder symptoms may be equally disturbing [Whorwell et al. 1986; Maxton et al. 1989].”
BackgroundSelf-citationTreatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis
Jackson, J. L., O’Malley, P. G., Tomkins, G., Balden, E., Santoro, J., & Kroenke, K. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00299-5 · Cited by 469 · cited 1×
“In the group of patients with painpredominant IBS antispasmodics often fail to achieve any worthwhile improvement and the next step is to try antidepressants, particularly those of the tricyclic variety [Jackson et al. 2000; Ford et al. 2009].”
BackgroundThe Narcotic Bowel Syndrome: Clinical Features, Pathophysiology, and Management
Grunkemeier, D. M. S., Cassara, J. E., Dalton, C. B., & Drossman, D. A. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.06.013 · Cited by 243 · cited 1×
“In some patients the prolonged use of opiates can lead to narcotic bowel syndrome and the continued use of the medication can lead to an actual exacerbation of the very pain that is being targeted, although the mechanism underlying this paradoxical effect has yet to be clearly defined [Grunkemeier et al. 2007; Choung…”
BackgroundHoughton, L. A., Fell, C., Whorwell, P. J., Jones, I., Sudworth, D. P., & Gale, J. D. (2007) · Gut · doi:10.1136/gut.2006.110858 · Cited by 204
Self-citationOpioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain
tuteja, A. K., biskupiak, J., stoddard, G. J., & lipman, A. G. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01458.x · Cited by 179 · cited 2×
“Unfortunately, all these latter analgesics are drugs of dependency and there is now emerging evidence that they can actually exacerbate pain and lead to narcotic bowel syndrome [Grunkemeier et al. 2007; Choung et al. 2009; Agostini et al. 2010; Tuteja et al. 2010; Drossman et al. 2012; Farmer et al. 2013; Manickam and…”
BackgroundThe burden of IBS: Looking at metrics
Spiegel, B. M. R. (2009) · Current Gastroenterology Reports · doi:10.1007/s11894-009-0039-x · Cited by 170 · cited 2×
“In addition, such individuals place a major burden on healthcare resources not only in primary care but also in secondary care where they are often submitted to multiple investigations as well as being frequent attendees at accident and emergency departments, sometimes requiring hospital admission [Talley, 1999; Spieg…”
BackgroundIrritable bowel syndrome: definition, diagnosis and epidemiology
Talley, N. J. (1999) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.1999.0033 · Cited by 114 · cited 2×
“In addition, such individuals place a major burden on healthcare resources not only in primary care but also in secondary care where they are often submitted to multiple investigations as well as being frequent attendees at accident and emergency departments, sometimes requiring hospital admission [Talley, 1999; Spieg…”
BackgroundRanking of symptoms by patients with the irritable bowel syndrome.
Maxton, D. G., Morris, J., & Whorwell, P. J. (1989) · BMJ · doi:10.1136/bmj.299.6708.1138 · Cited by 99
Self-citation
Cited by
British Society of Gastroenterology guidelines on the management of irritable bowel syndrome
Vasant, D. H., Paine, P. A., Black, C. J., Houghton, L. A., Everitt, H. A., Corsetti, M., Agrawal, A., Aziz, I., Farmer, A. D., Eugenicos, M. P., et al. (2021) · Gut · doi:10.1136/gutjnl-2021-324598 · Cited by 592
Stigma and irritable bowel syndrome: a taboo subject?
Hearn, M., Whorwell, P. J., & Vasant, D. H. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30348-6 · Cited by 88
Self-citationAvery, N., McNeilage, A. G., Stanaway, F., Ashton-James, C. E., Blyth, F. M., Martin, R., Gholamrezaei, A., & Glare, P. (2022) · BMJ · doi:10.1136/bmj-2021-066375 · Cited by 56
The management of adult patients with severe chronic small intestinal dysmotility
Nightingale, J. M. D., Paine, P., McLaughlin, J., Emmanuel, A., Martin, J. E., & Lal, S. (2020) · Gut · doi:10.1136/gutjnl-2020-321631 · Cited by 51
The global impact of IBS: time to think about IBS-specific models of care?
Corsetti, M., & Whorwell, P. (2017) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x17718677 · Cited by 50
Self-citation
Metadata
- Authors
- Pearson, J. S., Pollard, C., & Whorwell, P. J.
- Affiliations
- University of Manchester (GB)
- Wythenshawe Hospital (GB)
- ORCID
- Whorwell, Peter J.
- Venue
- Therapeutic Advances in Gastroenterology
- Publisher
- SAGE Publications
- Published
- 2014-06-19
- Volume
- 7
- Issue
- 6
- Pages
- 232-237
- ISSN
- 1756-283X (ISSN-L)
- 1756-2848
- PMC
- PMC4212468
- OpenAlex
- W2126197697
- Cited by
- 12
- References
- 16
- Citations by year
- 2026: 1 · 2025: 2 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 2 · 2017: 1 · 2016: 1
- FWCI
- 0.67
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Therapeutic Advances in Gastroenterology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
- Keywords
- irritable bowel syndrome, anticholinergic agents, abdominal pain, health care utilization, self-administered analgesia, general practitioners, emergency department visits
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Avoiding analgesic escalation and excessive healthcare utilization in severe irritable bowel syndrome: a role for intramuscular anticholinergics? https://app.cochat.ai/papers/10.1177/1756283x14540028
- The paper
- Pearson, J. S., Pollard, C., & Whorwell, P. J. (2014). Avoiding analgesic escalation and excessive healthcare utilization in severe irritable bowel syndrome: a role for intramuscular anticholinergics? Therapeutic Advances in Gastroenterology. https://doi.org/10.1177/1756283x14540028
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.